FactSet earnings beat sends shares up nearly 7% By Investing.com

FactSet beat Q2 adjusted EPS at $4.46 vs $4.37 consensus (+$0.09) and reported revenue of $611.0M vs $604.62M, up 7.1% YoY; shares rose ~6.7% pre-market. Management raised FY26 guidance to $17.25–$17.75 adjusted EPS (midpoint $17.50) and revenue to $2.45–$2.47B (midpoint $2.46B, above consensus). Organic ASV grew 6.7% YoY to $2,449.1M and the company lifted full-year organic ASV growth outlook to $130–$160M. GAAP diluted EPS fell 4.5% to $3.59 and adjusted operating margin compressed to 35.0% (from 37.3%) due to higher comp, tech costs and an impairment.

Analysis

FactSet’s re-acceleration is more structural than a quarter-to-quarter beat: management is converting deeper workflow integrations into higher ASV growth, which increases switching costs for incumbent buy-side systems. That dynamic favors vendors with sticky, embedded datasets and analytics — FactSet can monetize incremental seats and modules at high incremental gross margins, but the near-term P&L will look muted as they front-load comp and tech investments to cement that moat.

Second-order beneficiaries include boutique implementation vendors and SIs that integrate FactSet into client stacks (more recurring integration work), while pure-play data resellers without workflow offerings face pricing pressure. Conversely, competitors with broader fixed-cost bases (large index/data houses) will see margins diverge if they can’t match FactSet’s client-level integration; this creates an asymmetric opportunity for FactSet to take share in specialized workflows over 12–24 months.

Key risks are timing and concentration: an institutional budget slowdown or a big client churn would reveal the margin sacrifice taken to buy growth; impairment charges or continued comp inflation could compress free cash flow for 1–3 quarters and reset multiple expectations. Catalyst timeline: expect share-price re-rating on successive ASV beats over the next 2–4 quarters, while negative triggers include guide-downs, material client losses, or a sustained rise in operating leverage. The consensus is bullish on growth but underweights execution risk tied to integration cadence and near-term margin compression — the move is not binary and is best played with duration and hedges.

Key Decisions for Investors

• Long FDS equity (6–12 month horizon): initiate a 60–70% position of target exposure at the market with a price target implying ~+20–25% upside in 6–12 months, stop-loss at -12–15% to protect against a realization shock from margin misses.
• Long-dated call spread on FDS (12–18 months): buy the 12–18 month 25–30% OTM calls and sell 50% width higher strikes to cap cost — expected max return 2.5x premium if ASV momentum continues and margins stabilize; max loss = premium (~100% downside of premium).
• Pairs trade to hedge beta (6–12 months): long FDS / short SPGI notional-neutral (or LSEG if preferred) to isolate workflow/outgrowth thesis; target spread compression of 10–15% in relative performance if FactSet continues ASV acceleration, limit loss if macro-driven destocking hits both names.
• Event hedge (30–90 days): buy put protection on FDS covering next two quarters (one or two puts) sized to cap portfolio downside; use these puts as insurance around upcoming quarterly milestones where misses could trigger >15% moves.